Country: Велика Британија
Језик: Енглески
Извор: MHRA (Medicines & Healthcare Products Regulatory Agency)
Levonorgestrel
Bayer Plc
G03AC03
Levonorgestrel
30microgram
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 07030201; GTIN: 5016703000372
Page 1 of 10 V017_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack. Please compare the 'Leaflet prepared/revised date' towards the end of the leaflet to establish if there have been any changes. If you have any doubts or queries about your medication, please contact your doctor or pharmacist. _ _ PACKAGE LEAFLET: INFORMATION FOR THE USER Norgeston ® levonorgestrel FOUR IMPORTANT THINGS TO KNOW ABOUT THE PILL. The Pill will not protect you against sexually transmitted diseases. This medicine can increase your risk of problems such as blood clots and breast cancer. Some women should not take the Pill because of current medical problems or illnesses. Please read this leaflet to make sure Norgeston is right for you. To prevent pregnancy it is important to take Norgeston as instructed and start each pack on time. Please make sure that you understand what to do if you miss a pill or if you think you are pregnant. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, family planning nurse or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them. If you get any side effects, talk to your doctor, family planning nurse or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. IN THIS LEAFLET: 1 What Norgeston does 2 What you need to know before you take Norgeston 3 Taking Norgeston 3.3 A missed pill 4 Possible side effects 5 How to store Norgeston 6 What is in Norgeston and who makes it 1 What Norgeston does Norgeston is an oral contraceptive pill (the ‘mini Pill’). YOU TAKE IT TO STOP YOU GETTING PREGNANT. Norgeston contains a type of female sex hormone, called a progestogen. This hormone stops you getting pregnant by working in three ways: by making the fluid (mucus) in your cervix thicker, Page 2 Прочитајте комплетан документ
OBJECT 1 NORGESTON Summary of Product Characteristics Updated 21-Nov-2017 | Bayer plc 1. Name of the medicinal product Norgeston ® 2. Qualitative and quantitative composition 35 hormone-containing white tablets Each tablet contains: Actives:Levonorgestrel 30 micrograms Excipients with known effect: Lactose 33.12mg Sucrose 19.66mg For full list of excipients, see section 6.1. 3. Pharmaceutical form Sugar-coated tablets The tablets are biconvex, round and 5 mm in diameter. 4. Clinical particulars 4.1 Therapeutic indications Oral contraception. 4.2 Posology and method of administration _First treatment cycle: _One tablet daily, starting on the first day of the menstrual cycle, at a time of day chosen by the patient. All subsequent tablets must then be taken at this time. The contraceptive effect is likely to be reduced if a tablet is delayed by more than three hours. Additional contraceptive precautions are not necessary when initiating treatment. _Subsequent cycles:_ The tablets are taken daily and pack follows pack without interruption, and without regard to bleeding. _Changing from a combined oral contraceptive (COC):_ The first tablet of Norgeston should be taken on the first day after the last active tablet of the COC pack (In the case of every day (ED) tablet use, the inactive ones should be omitted). Additional contraceptive precautions are not required. _Changing from another POP: _The switch can be made at any time without interruption of contraceptive protection. _Changing from a progestogen-only parenteral method (implant, injection):_ The switch should be made before or when the next injection or implant is due. _Post-partum use:_ Norgeston can be initiated up to 21 days post-partum (no additional contraceptive is required). If started after 21 days additional barrier contraceptive methods should be used for 7 days. However, if intercourse has already occurred, pregnancy should be excluded before the actual start of Norgeston use or the woman has to wait for her first menstrual period. For additional in Прочитајте комплетан документ